SCOTTSDALE, Ariz., April 02, 2026--(BUSINESS WIRE)--Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient platform, today announced ...
When Sports Illustrated’s Albert Breer reported that both Brandon Beane and Joe Brady were credentialed at Ohio State’s Pro Day, Buffalo Bills fans immediately began pointing to a Buckeyes defender as ...
Macworld reports that Apple’s new M5 Pro and M5 Max MacBook Pro models represent a substantial upgrade with revolutionary Fusion Architecture separating CPU and GPU dies. These chips introduce “super ...
With the 2026 NFL Scouting Combine in the rearview, the prospect-evaluation process continues on with the pro day circuit, where NFL decision-makers will have another opportunity (in some cases their ...
At least 10 pro-Iranian protesters were killed in clashes with police as they tried to storm the gates of the US Consulate in Pakistan’s main port city of Karachi on Sunday. Security forces opened ...
Late last year, Google briefly took the crown for most powerful AI model in the world with the launch of Gemini 3 Pro — only to be surpassed within weeks by OpenAI and Anthropic releasing new models, ...
Grip is comfortable and easier to hold than camera alone. Large (customizable) shutter button. Programmable dial to control exposure. Adds 5-plus hours of battery life. Action cameras keep adding ...
Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Don’t ...
Eye redness was not a commonly reported side effect in clinical trials of YUVEZZI. In BRIO I and BRIO II the reports of adverse events of ocular hyperemia (eye redness) were low. 1,2 In BRIO II, the ...
The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA approval (PDF) for Yuvezzi, a treatment for presbyopia, a common, age-related ...